NuVasive Chooses Ohio For New Manufacturing Facility

NuVasive-OhioNuVasive, Inc. has selected a site in West Carrollton, OH as the location of its new medical device facility dedicated to spinal implant and instrument manufacturing. The company is in the process of finalizing a package of incentives that reflects a continued partnership with the state of Ohio.

“NuVasive’s plan to remain in the Dayton region will enable our community to keep roughly a hundred existing jobs with plans to add nearly 200 more,” said Debbie Lieberman, Montgomery County Commission President. “The area’s supply of a qualified workforce, various incentives and the efforts from a partnership between JobsOhio, the Dayton Development Coalition, Montgomery and Greene Counties and various local municipalities, have proven to be a deciding factor in the company’s decision to remain in the region.”

NuVasive plans to invest approximately $45 million over the next 24 months to build-out and equip the new facility. The 160,000-square-foot facility is scheduled to begin production by the end of 2016. The new facility will support the company’s efforts to increase its internal manufacturing capabilities alongside its existing manufacturing facility in Dayton, OH, and enhance its focus on operational excellence.

When at full scale, the new facility is expected to employ approximately 300 full-time, high-tech positions, including engineers and skilled machinists, as well as process development and validation specialists who will work with NuVasive’s research and development teams to optimize and accelerate product launches. The new facility will house state-of-the-art equipment, including approximately 100 computer numerical control (CNC) machine tools and CMM inspection equipment, as well as clean-room operations.

“We are happy to announce that we have selected a site in West Carrollton, OH as the location for our new medical device manufacturing facility,” said Gregory T. Lucier, NuVasive’s Chairman and Chief Executive Officer. “The site selection and subsequent build-out is a major step forward in our efforts to enhance our manufacturing presence in the United States to support the self-manufacture of nearly 100% of select spinal products and instruments. With this new facility and our longer-term plans to also expand our manufacturing footprint globally, we expect to increase customer responsiveness, dramatically improve inventory turns and speed up design time velocity to more efficiently meet the growing demand for our innovative spine technology.

“Our Ohio workforce is a critical part of our ongoing success and we are excited to expand our footprint and provide additional opportunities within the state,” he continued. “We greatly appreciate the support and cooperation of the Dayton Development Coalition and JobsOhio, as well as officials from both Montgomery County and the city of West Carrollton during the site selection process. I would like to personally thank Governor John R. Kasich and his office for their commitment to support incentives for NuVasive as we build out the new facility and train our expanded pool of employees who will support our growth in the region.NuVasive is well-known for our cutting-edge products and procedures and we look forward to building on this partnership and investing in the local community for years to come.”

“After an extensive search, we are thrilled NuVasive chose to expand their U.S. manufacturing asset in the Dayton region,” said Jeff Hoagland, President and Chief Executive Officer of the Dayton Development Coalition. “NuVasive’s investments in this new facility will retain and create hundreds of jobs for the region and support future development. Working together collaboratively with NuVasive and our community partners provided the support the company needed to stay in the Dayton region and continue to grow.”